HPA Axis Activity Due To Early Traumatic Stress and Metabolic Symptoms
- Conditions
- Childhood TraumaMajor Depressive Disorder
- Interventions
- Other: stress
- Registration Number
- NCT02398877
- Lead Sponsor
- Charite University, Berlin, Germany
- Brief Summary
This study evaluates the association between early trauma, depression and metabolic symptoms.
- Detailed Description
Early traumatic stress is associated with alterations of the hypothalamic-pituitary-adrenal axis (HPA-axis) indicated by an increased response to stress, a diminished negative feedback and alterations in expression of glucocorticoid receptors. Patients with a history of childhood trauma are more likely to develop metabolic disorders such as diabetes mellitus type 2 or metabolic syndrome.
The investigators will examine participants with and without early life stress and with and without major depression. The investigators assume that traumatized study participants (1) show an increased endocrine stress reaction to psychosocial stress, (2) display an altered sensitivity of GR, and (3) therefore suffer from an adverse cardiovascular risk profile in comparison to not-traumatized participants.
The investigators study will increase current knowledge on possible sequel of early traumatic stress. The results will lead to a more comprehensive understanding of stress-related eating behaviour and its implications.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 140
- diagnosis of MDD and/or experience of early trauma
- severe illness,
- control group: no diagnosis of MDD and experience of early trauma
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Depression without early trauma stress stress Depression with early trauma stress stress Healthy with early trauma stress stress Healthy without early trauma stress stress
- Primary Outcome Measures
Name Time Method Endocrine response to stress (salivary cortisol) 2 hours salivary cortisol
glucose to oral glucose tolerance test (plasma insulin) 2 hours plasma glucose
insulin to oral glucose tolerance test (plasma insulin) 2 hours plasma insulin
cortisol to corticotropin releasing factor (salivary cortisol) 3 hours salivary cortisol
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Charite University
🇩🇪Berlin, Germany